Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schwarz Generic Prilosec Clears FDA After Deal With Andrx, Genpharm

Executive Summary

Schwarz is expected to launch generic omeprazole by the end of year after FDA approval Nov. 1

You may also be interested in...



Pfizer Accupril Patent Victory Could Lead To Influx Of Generics In 2005

Accupril generics could enter the market as early as 2005 despite a court ruling finding a Pfizer quinapril patent to be valid

Pfizer Accupril Patent Victory Could Lead To Influx Of Generics In 2005

Accupril generics could enter the market as early as 2005 despite a court ruling finding a Pfizer quinapril patent to be valid

Teva, Ivax Move Closer To Marketing Generic Gabapentin

Teva and Ivax are moving into position to consider "at risk" launches of generic gabapentin (Pfizer's Neurontin)

Related Content

UsernamePublicRestriction

Register

PS040745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel